Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib

Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib

Abstract Glycogen storage disease type Ib (GSD Ib) is caused by biallelic variants in SLC37A4. GSD Ib is characterized by hepatomegaly, recurrent hypoglycemia, neutropenia, and neutrophil dysfunction. Only seven pregnancies in four women with GSD Ib have been reported so far. We report on two furthe...

Full description

Bibliographic Details
Main Authors: Sarah Catharina Grünert, Stefanie Rosenbaum‐Fabian, Anke Schumann, Anne‐Christine Selbitz, Waltraut Merz, Andrea Gieselmann, Ute Spiekerkoetter
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:JIMD Reports
Subjects:
empagliflozin
G‐CSF
glucose‐6‐phosphate transporter
glycogen storage disease type Ib
GSD Ib
pregnancy
Online Access:https://doi.org/10.1002/jmd2.12295

Internet

https://doi.org/10.1002/jmd2.12295

Similar Items